Evidence map›Paper›PMID 36224602›Full record

ArticleBMC medicine2022

Early onset of immune-mediated diseases in minority ethnic groups in the UK.

Archana Sharma-Oates, Dawit T Zemedikun, Kanta Kumar, John A Reynolds, Avinash Jain, Karim Raza, John A Williams, Laura Bravo, Victor Roth Cardoso, Georgios Gkoutos and 2 more

Open access · goldAbstract read
In one paragraph

Article in BMC medicine, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed, 1 pooled it
2.0field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 1 synthesis or guideline pooled it, 20 citations in OpenAlex.

  1. Guideline
  2. Article
  3. Article
  4. Article
  5. Review
  6. Review
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 5 institutions in 2 countries.

Archana Sharma-Oates *Institute of Inflammation and Ageing, University of Birmingham, Birmingham, B15 2TT, UK. a.sharma-oates@bham.ac.uk.ORCID 0000-0003-1503-5858
Dawit T Zemedikun *Institute of Applied Health Research, University of Birmingham, Birmingham, B15 2TT, UK.
Kanta KumarInstitute of Clinical Sciences, University of Birmingham, Birmingham, B15 2TT, UK.
John A ReynoldsInstitute of Inflammation and Ageing, University of Birmingham, Birmingham, B15 2TT, UK.
Avinash JainSMS Medical College, Jaipur, Rajasthan, India.
Karim RazaInstitute of Inflammation and Ageing, University of Birmingham, Birmingham, B15 2TT, UK.
John A WilliamsDepartment of Rheumatology, Sandwell and West Birmingham NHS Trust, Birmingham, UK.
Laura BravoInstitute of Cancer and Genomic Sciences, University of Birmingham, Birmingham, B15 2TT, UK.
Victor Roth CardosoHealth Data Research UK, Midlands Site, Birmingham, B15 2TT, UK.
Georgios GkoutosHealth Data Research UK, Midlands Site, Birmingham, B15 2TT, UK.
Krishnarajah NirantharakumarInstitute of Applied Health Research, University of Birmingham, Birmingham, B15 2TT, UK.
Janet M LordInstitute of Inflammation and Ageing, University of Birmingham, Birmingham, B15 2TT, UK.
University of Birmingham · GBHealth Data Research UK · GBSandwell & West Birmingham Hospitals NHS Trust · GBArthritis UK · GBSMS Medical College · IN

Funding

Department of HealthMedical Research Council MC_PC_17228Medical Research Council MC_QA137853Medical Research Council MR/P021220/1
6 · The paper itself

Abstract

backgroundThe prevalence of some immune-mediated diseases (IMDs) shows distinct differences between populations of different ethnicities. The aim of this study was to determine if the age at diagnosis of common IMDs also differed between different ethnic groups in the UK, suggestive of distinct influences of ethnicity on disease pathogenesis.

methodsThis was a population-based retrospective primary care study. Linear regression provided unadjusted and adjusted estimates of age at diagnosis for common IMDs within the following ethnic groups: White, South Asian, African-Caribbean and Mixed-race/Other. Potential disease risk confounders in the association between ethnicity and diagnosis age including sex, smoking, body mass index and social deprivation (Townsend quintiles) were adjusted for. The analysis was replicated using data from UK Biobank (UKB).

resultsAfter adjusting for risk confounders, we observed that individuals from South Asian, African-Caribbean and Mixed-race/Other ethnicities were diagnosed with IMDs at a significantly younger age than their White counterparts for almost all IMDs. The difference in the diagnosis age (ranging from 2 to 30 years earlier) varied for each disease and by ethnicity. For example, rheumatoid arthritis was diagnosed at age 49, 48 and 47 years in individuals of African-Caribbean, South Asian and Mixed-race/Other ethnicities respectively, compared to 56 years in White ethnicities. The earlier diagnosis of most IMDs observed was validated in UKB although with a smaller effect size.

conclusionIndividuals from non-White ethnic groups in the UK had an earlier age at diagnosis for several IMDs than White adults.

Indexed as

EthnicityWhite PeopleAdolescentAdultBlack PeopleChildChild, PreschoolHumansRetrospective StudiesUnited KingdomYoung AdultAfrican-CaribbeanAgeingAutoimmune inflammatory diseasesDiagnosisEthnicityImmune-mediated diseasesRheumatic diseasesSouth Asian

Identifiers

PMID36224602
PMCPMC9558944
OpenAlexW4304759259

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.